Huyabio International, Llc.
Clinical trials sponsored by Huyabio International, Llc., explained in plain language.
-
New infusion drug aims to stop irregular heartbeat in its tracks
Disease control OngoingThis study tests a single 30-minute IV infusion of HBI 3000 in 150 adults aged 18–80 who have had atrial fibrillation (irregular heartbeat) for 2 to 72 hours. The goal is to see if the drug can safely and quickly convert the heart back to normal rhythm. The trial first finds the …
Phase: PHASE2 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated May 17, 2026 12:58 UTC
-
New combo shows promise in Late-Stage melanoma trial
Disease control OngoingThis study tests whether adding HBI-8000 to the standard immunotherapy nivolumab helps people with advanced melanoma live longer without their cancer growing. About 450 adults with melanoma that cannot be removed by surgery or has spread will take part. Half get HBI-8000 plus niv…
Phase: PHASE3 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated May 17, 2026 12:57 UTC